Monthly Archives: December 2018

XTALKS PRESS RELEASE FOR Nitto Avecia Pharma (April 17/18 Webinar)

HEADLINE Cell-Based Assays in a CGMP Environment: Approaches for Clinical and Commercial Stability Studies, New Webinar Hosted by Xtalks. SUB-HEADLINE Presentation to highlight the approaches used in developing consistent cell-based potency assays meeting regulatory expectations (USP <1032> and <1033>) and are suitable for CGMP stability testing. SUMMARY Potency of biotherapeutics, often determined by cell-based assays, … Continue reading XTALKS PRESS RELEASE FOR Nitto Avecia Pharma (April 17/18 Webinar)

Avecia Announces Opening of Cambridge, MA Office

CAMBRIDGE, MA – Nitto Denko Avecia, Inc. (Avecia), a leader in oligonucleotide API (active pharmaceutical ingredient) manufacturing, announced today the opening of a new corporate office in Cambridge, MA, to support its operations and corporate development activities, and to be more accessible to clients. Detlef Rethage, President of Avecia stated, “The new office, located in Kendall … Continue reading Avecia Announces Opening of Cambridge, MA Office